Lillestol Research

< Return to trials

Female Orgasmic Disorder (FOD)

Overview

Lillestol Research has trial experience in the female orgasmic disorder (FOD) indication/diagnosis. Our research patient database also presents many females with this diagnosis that would be interested in clinical trial participation.

Spotlight Trial(s)

This was an investigational product, placebo-controlled trial for females suffering from acquired female orgasmic disorder (FOD). The study objective was a dose range trial vs. placebo on the intended effect of occurrence of orgasm. Lillestol Research was able to successfully meet the sponsor’s enrollment expectation randomizing 7 patients in a 7-month enrollment period.